Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced Liver Cancers × Bevacizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 32 Glioblastoma 23 Carcinoma, Non-Small-Cell Lung 19 Ovarian Neoplasms 13 Brain Neoplasms 12 Pancreatic Neoplasms 11 Glioma 10 Carcinoma, Renal Cell 10 Breast Neoplasms 10 Neoplasms 9 Carcinoma, Hepatocellular 9 Neoplasm Metastasis 8 Colonic Neoplasms 8 Astrocytoma 8 Melanoma 7 Uterine Cervical Neoplasms 6 Rectal Neoplasms 6 Gliosarcoma 6 Lung Neoplasms 5 Fallopian Tube Neoplasms 5 Endometrial Neoplasms 5 Colorectal Cancer Metastatic 5 Advanced Solid Tumors 5 Stomach Neoplasms 4 Oligodendroglioma 4 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Liver Neoplasms 3 Diffuse Intrinsic Pontine Glioma 3 Advanced Solid Tumor 3

Interventions

tocilizumab 1 atezolizumab 1 Tiragolumab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04524871 2026-02-27

MORPHEUS-LIVER

Hoffmann-La Roche

Phase 1/2 Recruiting

Advanced Liver Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡